{
    "nctId": "NCT01261832",
    "title": "Randomized, Prospective , Open Label, Phase 4 Trial of Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention With Drug-eluting Stent",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Acute Myocardial Infarction Undergoing Primary percutaneous coronary intervention"
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 18 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "The patient has a known hypersensitivity or contraindication to any of the following medications: Heparin, Aspirin, Clopidogrel, Cilostazol"
                            },
                            {
                                "type": "variable",
                                "value": "Uncontrolled hypertension"
                            },
                            {
                                "type": "variable",
                                "value": "History of bleeding diathesis or known coagulopathy (including heparin-induced thrombocytopenia), or refuses blood transfusions."
                            },
                            {
                                "type": "variable",
                                "value": "Baseline hemogram with Hb<10g/dL or PLT count<100,000/\u03bcL"
                            },
                            {
                                "type": "variable",
                                "value": "Patients already taking warfarin, cilostazol or any other type of anti-platelet agents except aspirin and clopidogrel"
                            },
                            {
                                "type": "variable",
                                "value": "Gastrointestinal or genitourinary bleeding within the prior 3 months, or major surgery within 2 months"
                            },
                            {
                                "type": "variable",
                                "value": "Pregnancy"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Acute Myocardial Infarction Undergoing Primary percutaneous coronary intervention'), Symbol('Must have minimum age of 18 Years'), Not(Or(Symbol('Baseline hemogram with Hb<10g/dL or PLT count<100,000/\u03bcL'), Symbol('Gastrointestinal or genitourinary bleeding within the prior 3 months, or major surgery within 2 months'), Symbol('History of bleeding diathesis or known coagulopathy (including heparin-induced thrombocytopenia), or refuses blood transfusions.'), Symbol('Patients already taking warfarin, cilostazol or any other type of anti-platelet agents except aspirin and clopidogrel'), Symbol('Pregnancy'), Symbol('The patient has a known hypersensitivity or contraindication to any of the following medications: Heparin, Aspirin, Clopidogrel, Cilostazol'), Symbol('Uncontrolled hypertension'))))"
}